CV Sciences, Inc., a life sciences organization, is focused on promoting healthy living through their pharmaceutical drug development efforts and portfolio of finished product brands. CV Sciences’ Pharmaceutical Division is developing synthetically‐formulated cannabidiol‐based medicine, pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications utilizing cannabidiol as the active pharmaceutical ingredient. CV Sciences’ Consumer Products Division delivers botanical‐based cannabidiol products.